FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndOperating margin (%) YoY (%)
Mar 31, 20258.6-444.20%
Mar 31, 2024-2.5-86.69%
Mar 31, 2023-18.9-219.86%
Mar 31, 202215.7+221.97%
Mar 31, 20214.9-160.65%
Mar 31, 2020-8.1-471.62%
Mar 31, 20192.2+49.20%
Mar 31, 20181.5-113.51%
Mar 31, 2017-10.8-1743.70%
Mar 31, 20160.7-84.55%
Mar 31, 20154.2
AI Chat